Literature DB >> 2871901

Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique.

T S Jensen, T L Yaksh.   

Abstract

In rats stereotaxically implanted with microinjection cannula in either the periaqueductal gray matter (PAG) or the medial/paramedial medullary reticular formation (MRF), microinjection of morphine, sufentanil, D-Ala2-D-Leu5-enkephalin (DADL) or D-Ser2-Thr6-leucine enkephalin (DSTLE) produced dose-dependent elevations in the response latency on tail-flick and hot plate tests. These effects were reversed by naloxone administered by microinjection into the same intracerebral site. Both mu (morphine and sufentanil) and delta (DADL and DSTLE) opioid receptor ligands produced a maximal elevation in the supraspinally mediated hot plate response when administered into either the PAG or the MRF. Similarly, mu and delta receptor ligands produced maximum elevations in the spinally mediated tail-flick response when microinjected into the PAG. In contrast, delta, but not mu, receptor agonists produced a total blockade of the tail-flick response following administration into the MRF. Microinjection of mu (morphine) or delta (DADL) agonists into the PAG or the MRF also resulted in a naloxone-reversible inhibition of the visceral chemical evoked writhing response. These observations suggest that mu and delta opioid receptor linked systems within the MRF but not the PAG produce their antinociceptive effects by discriminable mechanisms with a differential action on spinopetal vs supraspinal modulatory systems.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871901     DOI: 10.1016/0006-8993(86)91138-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  22 in total

1.  PAG mu opioid receptor activation underlies sex differences in morphine antinociception.

Authors:  Scott A Bernal; Michael M Morgan; Rebecca M Craft
Journal:  Behav Brain Res       Date:  2006-11-21       Impact factor: 3.332

2.  Sex differences in the anatomical and functional organization of the periaqueductal gray-rostral ventromedial medullary pathway in the rat: a potential circuit mediating the sexually dimorphic actions of morphine.

Authors:  Dayna R Loyd; Anne Z Murphy
Journal:  J Comp Neurol       Date:  2006-06-10       Impact factor: 3.215

3.  Persistent pain model reveals sex difference in morphine potency.

Authors:  Xiaoya Wang; Richard J Traub; Anne Z Murphy
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-02-23       Impact factor: 3.619

Review 4.  Development of delta opioid peptides as nonaddicting analgesics.

Authors:  R S Rapaka; F Porreca
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

Review 5.  Opioid receptors and pain.

Authors:  R Dirksen
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

Review 6.  Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  Peptides       Date:  2019-03-16       Impact factor: 3.750

7.  A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception.

Authors:  F S Hall; J M Schwarzbaum; M T G Perona; J S Templin; M G Caron; K-P Lesch; D L Murphy; G R Uhl
Journal:  Neuroscience       Date:  2010-12-01       Impact factor: 3.590

8.  Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.

Authors:  K Lutfy; N T Maidment
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

9.  Analgesia induced by localized injection of opiate peptides into the brain of infant rats.

Authors:  G A Barr; S Wang
Journal:  Eur J Pain       Date:  2012-12-03       Impact factor: 3.931

10.  Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats.

Authors:  J M DeSantana; L F S Da Silva; M A De Resende; K A Sluka
Journal:  Neuroscience       Date:  2009-07-02       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.